Provided by Tiger Trade Technology Pte. Ltd.

Harvard Bioscience

0.7543
+0.00080.11%
Volume:375.59K
Turnover:289.08K
Market Cap:33.63M
PE:-0.62
High:0.7997
Open:0.7760
Low:0.7507
Close:0.7535
52wk High:2.28
52wk Low:0.2813
Shares:44.58M
Float Shares:33.77M
Volume Ratio:0.47
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2193
EPS(LYR):-0.2849
ROE:-135.62%
ROA:-0.82%
PB:2.39
PE(LYR):-2.65

Loading ...

Harvard Bioscience Inc - Loan Agreement Includes Term Loans Totaling $40 Mln - SEC Filing

THOMSON REUTERS
·
Dec 17

Harvard Bioscience Secures $40 Million Credit Facility from BroadOak Capital Partners

Reuters
·
Dec 17

Harvard Bioscience Inc - Announces $40 Mln Credit Facility With Broadoak

THOMSON REUTERS
·
Dec 17

Harvard Bioscience Announces the Successful Completion of Debt Refinancing With Comprehensive Growth Financing Package

THOMSON REUTERS
·
Dec 17

Harvard Bioscience Plans Refinancing of Credit Agreement with Bank Consortium

Reuters
·
Dec 06

Harvard Bioscience Q3 Revenue USD 20.591 Million

Reuters
·
Nov 20

Benchmark Co. Keeps Their Buy Rating on Harvard Bioscience (HBIO)

TIPRANKS
·
Nov 07

Harvard Bioscience sees Q4 revenue $22.5M-$24.5M

TIPRANKS
·
Nov 06

Harvard Bioscience Q3 Sales $20.591M Beat $20.000M Estimate

Benzinga
·
Nov 06

Harvard Bioscience Reports Q3 Revenue of $20.6 Million and Net Loss of $1.2 Million

Reuters
·
Nov 06

BRIEF-Harvard Bioscience Q3 Revenue USD 20.591 Million

Reuters
·
Nov 06

Harvard Bioscience Inc expected to post earnings of 1 cent a share - Earnings Preview

Reuters
·
Nov 04

Harvard Bioscience Inc. to Release Third Quarter 2025 Results

Reuters
·
Oct 30

Harvard Bioscience Inc. Files Initial Beneficial Ownership Statement for Director Stephen J. DeNelsky

Reuters
·
Oct 08

BRIEF-Harvard Bioscience Granted 180 Days For Compliance - SEC Filing

Reuters
·
Oct 03

Harvard Bioscience Inc - Granted 180 Days or Until March 30, 2026 by Nasdaq for Compliance - SEC Filing

THOMSON REUTERS
·
Oct 03

Harvard Bioscience Granted Additional 180 Days by Nasdaq to Regain $1 Minimum Bid Price Compliance

Reuters
·
Oct 03

Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States

GlobeNewswire
·
Sep 16

Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Sep 10

Harvard Bioscience Announces Appointment of Stephen Denelsky to Board of Directors

THOMSON REUTERS
·
Sep 09